How can I differentiate anemia caused by chronic kidney disease from pure iron‑deficiency anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differentiating Anemia of Chronic Kidney Disease from Pure Iron-Deficiency Anemia

The key to distinguishing kidney-related anemia from pure iron deficiency lies in using different ferritin and transferrin saturation thresholds: in CKD, absolute iron deficiency is defined by ferritin ≤100 ng/mL (predialysis/peritoneal dialysis) or ≤200 ng/mL (hemodialysis) with TSAT ≤20%, whereas in patients without CKD, ferritin <30 ng/mL with TSAT <16-20% confirms iron deficiency. 1, 2

Laboratory Thresholds That Distinguish CKD-Related Anemia

In Chronic Kidney Disease Patients

  • Absolute iron deficiency in CKD is diagnosed when TSAT ≤20% and serum ferritin ≤100 ng/mL (for predialysis and peritoneal dialysis patients) or ≤200 ng/mL (for hemodialysis patients). 1, 2

  • Functional iron deficiency in CKD (iron-restricted erythropoiesis) is characterized by TSAT ≤20% with elevated ferritin levels (>100-200 ng/mL depending on dialysis status), indicating adequate iron stores but insufficient iron availability due to elevated hepcidin from chronic inflammation. 1, 2, 3

  • The higher ferritin thresholds in CKD reflect that ferritin is an acute-phase reactant and becomes falsely elevated by the chronic inflammatory state inherent to kidney disease. 1

In Patients Without CKD (Pure Iron Deficiency)

  • Pure iron deficiency is diagnosed when ferritin <30 μg/L without clinical, endoscopic, or biochemical evidence of inflammation. 1

  • When inflammation is absent, ferritin <15 μg/L provides 99% specificity for depleted iron stores. 4

  • TSAT <16-20% confirms iron deficiency in non-CKD patients, particularly when ferritin may be falsely elevated by concurrent inflammation. 1

Clinical Context That Points to CKD as the Cause

Assess Kidney Function First

  • Measure serum creatinine and estimated GFR to establish whether CKD is present; anemia in CKD typically appears when eGFR falls below 60 mL/min/1.73m² (stage 3 or higher). 2, 5

  • The presence of CKD fundamentally changes the diagnostic criteria for iron deficiency, requiring higher ferritin thresholds. 1, 2

Look for Functional Iron Deficiency Pattern

  • TSAT ≤20% with ferritin 100-700 ng/mL suggests functional iron deficiency from CKD-related inflammation, where iron stores are adequate but unavailable for erythropoiesis due to elevated hepcidin. 1, 2

  • In contrast, pure iron deficiency shows both low ferritin (<30 ng/mL) and low TSAT (<20%). 1

  • If serial ferritin levels decrease during erythropoietin therapy while remaining >100 ng/mL, this confirms functional iron deficiency; an abrupt increase in ferritin with sudden TSAT drop indicates an inflammatory block. 1

Bone Marrow Examination Provides Definitive Distinction

  • In CKD patients with anemia, bone marrow biopsy showing absent iron stores despite ferritin 100-300 ng/mL confirms that the elevated ferritin is falsely elevated by inflammation and true iron deficiency exists. 6

  • This finding is common: 46 of 47 consecutive CKD patients with anemia had no bone marrow iron deposits despite mean ferritin of 236 μg/L. 6

Algorithmic Approach to Differentiation

  1. Obtain baseline labs: hemoglobin, MCV, serum creatinine, eGFR, ferritin, TSAT, and C-reactive protein. 1, 2, 5

  2. Determine if CKD is present:

    • eGFR ≥60 mL/min/1.73m² → use standard iron deficiency criteria (ferritin <30 ng/mL, TSAT <20%)
    • eGFR <60 mL/min/1.73m² → use CKD-specific criteria (ferritin ≤100-200 ng/mL, TSAT ≤20%) 1, 2
  3. Interpret ferritin in context of kidney function:

    • No CKD + ferritin <30 ng/mL → pure iron deficiency 1
    • CKD + ferritin ≤100 ng/mL (or ≤200 if on hemodialysis) + TSAT ≤20% → absolute iron deficiency in CKD 1, 2
    • CKD + ferritin >100 ng/mL + TSAT ≤20% → functional iron deficiency from CKD 1, 2
  4. If ferritin is 30-100 ng/mL without CKD:

    • Measure CRP to assess for inflammation
    • If CRP elevated, ferritin up to 100 μg/L may still indicate iron deficiency 1
    • TSAT <20% with ferritin >100 μg/L suggests anemia of chronic disease 1
  5. Consider trial of IV iron to distinguish functional from inflammatory block:

    • Give 50-125 mg IV iron weekly for 8-10 doses
    • Erythropoietic response (hemoglobin increase) confirms functional iron deficiency
    • No response suggests inflammatory block 1

Critical Pitfalls to Avoid

  • Do not use the same ferritin threshold (<30 ng/mL) for CKD patients as for those without kidney disease; this will miss the majority of iron-deficient CKD patients whose ferritin is falsely elevated by inflammation. 1, 2

  • Do not assume ferritin 100-300 ng/mL excludes iron deficiency in CKD; bone marrow examination often reveals absent iron stores at these ferritin levels due to chronic inflammation. 6

  • Do not rely on ferritin alone when inflammation is present (elevated CRP); always calculate TSAT, as it more accurately reflects iron available for erythropoiesis. 1

  • Recognize that normocytic anemia can occur in both conditions; CKD typically causes normocytic anemia of chronic disease, while combined iron and folate/B12 deficiency can mask microcytosis. 1

  • In CKD patients with TSAT <20% and ferritin 100-700 ng/mL, distinguish functional iron deficiency from inflammatory block by monitoring serial ferritin trends or giving a trial of IV iron. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Iron Deficiency in Chronic Kidney Disease: Updates on Pathophysiology, Diagnosis, and Treatment.

Journal of the American Society of Nephrology : JASN, 2020

Guideline

Management of Microcytic Hypochromic Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.